Premium
COVID ‐19 and implications for thiopurine use
Author(s) -
Goodsall Thomas M,
Costello Samuel P,
Bryant Robert V
Publication year - 2020
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.50613
Subject(s) - queen (butterfly) , covid-19 , medical journal , citation , library science , medicine , family medicine , computer science , disease , infectious disease (medical specialty) , hymenoptera , botany , pathology , biology
Traditionally, thiopurine use has been associated with an increased risk of opportunistic viral infections.1–3 A large IBD registry study found that using thiopurines and having active disease were associated with a higher risk of serious viral infection.3 However, all identified causative agents were species of the Herpesviridae genus.1–3 The risk associated with thiopurine use can therefore not yet be generalised to other virus genera, and indeed only corticosteroid use is associated with risk of contracting influenza in patients with IBD.4